Three independent discounted-cash-flow-style models value Novavax Inc every trading day. 0 of 3 currently price NVAX above its market price.
| Free Cash Flow model | $-43.71 |
| Excess Profit model | $-16.88 |
| Residual Earnings model | $-0.14 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +49.9% |
| Net debt / EBITDA | 1.3× |
| Gross margin | +93.5% |
| Revenue CAGR | -17.2% |
| Cash conversion | -0.6× |
| Dividend yield | — |
| Buyback yield | -6.4% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open NVAX in StockKitty